Compare MKTX & MMSI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | MKTX | MMSI |
|---|---|---|
| Founded | 2000 | 1987 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Investment Bankers/Brokers/Service | Medical/Dental Instruments |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 6.0B | 5.3B |
| IPO Year | 2004 | 1990 |
| Metric | MKTX | MMSI |
|---|---|---|
| Price | $171.51 | $93.38 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 11 | 8 |
| Target Price | ★ $210.27 | $106.13 |
| AVG Volume (30 Days) | ★ 724.1K | 610.3K |
| Earning Date | 02-05-2026 | 02-24-2026 |
| Dividend Yield | ★ 1.75% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 5.87 | 1.95 |
| Revenue | $839,263,000.00 | ★ $1,477,128,000.00 |
| Revenue This Year | $6.33 | $13.53 |
| Revenue Next Year | $8.10 | $6.30 |
| P/E Ratio | ★ $29.58 | $46.97 |
| Revenue Growth | 3.37 | ★ 11.41 |
| 52 Week Low | $156.17 | $78.12 |
| 52 Week High | $232.84 | $111.45 |
| Indicator | MKTX | MMSI |
|---|---|---|
| Relative Strength Index (RSI) | 39.88 | 68.44 |
| Support Level | $177.31 | $85.70 |
| Resistance Level | $183.15 | $94.75 |
| Average True Range (ATR) | 3.00 | 2.17 |
| MACD | -1.39 | 0.55 |
| Stochastic Oscillator | 9.24 | 82.23 |
Founded in 2000, MarketAxess is a leading electronic fixed-income trading platform that connects broker/dealers and institutional investors. The company is primarily focused on credit based fixed income securities with its main trading products being US investment-grade and high-yield bonds, Eurobonds, and Emerging Market corporate debt. Recently the company has expanded more aggressively into Treasuries and municipal bonds with the acquisitions of LiquidityEdge and MuniBrokers in 2019 and 2021, respectively. The company also provides pre- and post-trade services with its acquisition of Regulatory Reporting Hub from Deutsche Börse Group in 2020 adding to its product offerings.
Merit Medical Systems Inc is a medical equipment company that develops and manufactures products for interventional cardiology, radiology, and endoscopy procedures. The firm reports two segments which are Cardiovascular and Endoscopy. The majority of the revenue is earned from the Cardiovascular segment which consists of cardiology and radiology medical device products that assist in diagnosing and treating coronary artery disease, peripheral vascular disease, and other non-vascular diseases and includes embolotherapeutic, cardiac rhythm management, electrophysiology, critical care, and interventional oncology and spine devices.